Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial.
Ashenburg
R J
RJ
D000293:Adolescent; D004087:Dihydroergotamine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004881:Ergotism / Q000209:etiology; D006493:Heparin / Q000008:administration & dosage* / Q000627:therapeutic use; D006622:Hip Prosthesis; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control*; D013923:Thromboembolism / Q000517:prevention & control*
D004087:Dihydroergotamine; D006493:Heparin